Syneos Health is a fully integrated biopharmaceutical solutions organization that combines clinical development, medical affairs, and commercial expertise. The company's model is designed to support biopharmaceutical clients from early-phase development through product launch and beyond. Its integrated approach has contributed to the development or commercialization of 96% of novel oncology drugs approved by the FDA and 93% of oncology products granted marketing authorization by the EMA in recent five-year periods.
The company operates globally, with a presence in 110 countries and a workforce of approximately 29,000 employees. Its primary industry verticals are biopharmaceuticals and oncology. For technology professionals, the organization's work spans data-driven clinical development and the systems supporting commercialization insights.
